Yangchao Chen

8.0k total citations
149 papers, 6.2k citations indexed

About

Yangchao Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yangchao Chen has authored 149 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 48 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Yangchao Chen's work include MicroRNA in disease regulation (29 papers), RNA modifications and cancer (28 papers) and Cancer-related molecular mechanisms research (26 papers). Yangchao Chen is often cited by papers focused on MicroRNA in disease regulation (29 papers), RNA modifications and cancer (28 papers) and Cancer-related molecular mechanisms research (26 papers). Yangchao Chen collaborates with scholars based in China, Hong Kong and United States. Yangchao Chen's co-authors include Chi Han Li, Hsiang‐Fu Kung, Ming‐Liang He, Chi Hin Wong, Marie C.M. Lin, Ka‐Fai To, George Stamatoyannopoulos, Chao-Zhong Song, Joseph J.�Y. Sung and Dan Xie and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Yangchao Chen

138 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangchao Chen China 45 4.4k 2.3k 697 485 422 149 6.2k
Bülent Özpolat United States 45 4.3k 1.0× 1.7k 0.7× 904 1.3× 931 1.9× 667 1.6× 147 6.4k
Cornelia Braicu Romania 41 3.0k 0.7× 1.7k 0.7× 718 1.0× 250 0.5× 382 0.9× 163 5.4k
Wen Liu China 45 5.0k 1.1× 1.1k 0.5× 952 1.4× 455 0.9× 892 2.1× 226 7.2k
Danny N. Dhanasekaran United States 38 3.3k 0.7× 1.2k 0.5× 638 0.9× 540 1.1× 609 1.4× 107 5.2k
Matilde E. Lleonart Spain 38 3.7k 0.8× 1.8k 0.7× 1.3k 1.9× 428 0.9× 339 0.8× 86 5.6k
Xueying Sun China 48 3.4k 0.8× 1.7k 0.7× 1.2k 1.7× 833 1.7× 829 2.0× 187 6.8k
Hani Choudhry Saudi Arabia 34 3.3k 0.7× 1.9k 0.8× 531 0.8× 221 0.5× 427 1.0× 150 5.2k
Lingzhi Wang Singapore 45 3.6k 0.8× 1.8k 0.8× 1.5k 2.1× 334 0.7× 630 1.5× 148 6.4k
Hu Zhou China 42 5.1k 1.1× 1.8k 0.8× 736 1.1× 468 1.0× 366 0.9× 212 7.0k
Ji‐Ye Yin China 41 2.7k 0.6× 1.3k 0.5× 1.1k 1.6× 358 0.7× 523 1.2× 197 5.1k

Countries citing papers authored by Yangchao Chen

Since Specialization
Citations

This map shows the geographic impact of Yangchao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangchao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangchao Chen more than expected).

Fields of papers citing papers by Yangchao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangchao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangchao Chen. The network helps show where Yangchao Chen may publish in the future.

Co-authorship network of co-authors of Yangchao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yangchao Chen. A scholar is included among the top collaborators of Yangchao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangchao Chen. Yangchao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dawei, Tong Chen, Kai Han, et al.. (2025). Targeting Protein Tyrosine Phosphatase Nonreceptor Type 2 with a Novel Inhibitor for the Treatment of Melanoma. Journal of Medicinal Chemistry. 68(22). 24649–24671.
2.
Wang, Chong, et al.. (2025). Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy. Cancer Immunology Immunotherapy. 74(3). 92–92. 2 indexed citations
3.
Chen, Yan, et al.. (2024). Long non-coding RNAs-sphingolipid metabolism nexus: Potential targets for cancer treatment. Pharmacological Research. 210. 107539–107539. 1 indexed citations
4.
Chen, Gang, Zhao‐Xi Wang, Yuqi Yang, et al.. (2024). Elucidation of the mechanism underlying the sequential catalysis of inulin by fructotransferase. International Journal of Biological Macromolecules. 277(Pt 3). 134446–134446. 3 indexed citations
5.
Zhong, Haojie, et al.. (2024). Exploring the impact of gut microbiota on liver health in mice and patients with Wilson disease. Liver International. 44(10). 2700–2713. 2 indexed citations
6.
Wong, Chi Hin, et al.. (2023). Circularized RNA as novel therapeutics in cancer. The International Journal of Biochemistry & Cell Biology. 156. 106364–106364. 6 indexed citations
7.
Feng, Yugong, et al.. (2020). Long Non-Coding RNAs Regulate Inflammation in Diabetic Peripheral Neuropathy by Acting as ceRNAs Targeting miR-146a-5p. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Song, Jie, Yangchao Chen, Dalin He, et al.. (2020). Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Wang, Chao, et al.. (2020). SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Xu, Feiyue, Chi Han Li, Chi Hin Wong, et al.. (2019). Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma. Cancer Research. 79(7). 1305–1317. 29 indexed citations
11.
Chen, Yangchao, et al.. (2019). Role of Hippo/YAP signaling in irradiation-induced glioma cell apoptosis. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Chen, Yangchao, et al.. (2019). Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Ji, Lin, Jia Chen, Ying‐Ping Wang, et al.. (2019). Therapeutic potential of pravastatin for random skin flaps necrosis: involvement of promoting angiogenesis and inhibiting apoptosis and oxidative stress. SHILAP Revista de lepidopterología.
14.
Ma, Yuanyuan, et al.. (2019). Assessment of COPD-Related Knowledge Among Internal Medicine Nurses: A Cross-Sectional Study. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Wang, Yuhe, Michelle Kang, Hu Ding, et al.. (2017). The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Xiao, Zhangang, Chi Han Li, Stephen L. Chan, et al.. (2014). A Small-Molecule Modulator of the Tumor-Suppressor miR34a Inhibits the Growth of Hepatocellular Carcinoma. Cancer Research. 74(21). 6236–6247. 74 indexed citations
17.
Lü, Juan, Ming‐Liang He, Lu Wang, et al.. (2011). MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2. Cancer Research. 71(1). 225–233. 328 indexed citations
18.
Cheng, Alfred S.L., Suki S. Lau, Yangchao Chen, et al.. (2011). EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis. Cancer Research. 71(11). 4028–4039. 180 indexed citations
19.
Wang, Hua, Yangchao Chen, Chu‐yan Chan, et al.. (2010). Hsa‐let‐7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c‐Myc and upregulation of p16INK4A. International Journal of Cancer. 128(2). 319–331. 136 indexed citations
20.
Zhang, Bin, Feng Feng, Rui Jin, et al.. (2008). Silencing PinX1 Compromises Telomere Length Maintenance As Well As Tumorigenicity in Telomerase-Positive Human Cancer Cells. Cancer Research. 69(1). 75–83. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026